UBS analyst Thomas Wadewitz raised the firm’s price target on C.H. Robinson (CHRW) to $177 from $166 and keeps a Buy rating on the shares. UBS expects a positive response from the stock to the strong Q3 report and increase in 2026 EBIT target, the analyst tells investors in a research note. The firm believes the Q4 cost comments are somewhat conservative.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHRW:
- C.H. Robinson price target raised to $138 from $115 at TD Cowen
- C.H. Robinson price target raised to $166 from $155 at JPMorgan
- CH Robinson: Balanced Risk and Reward Amid Short-Term Uncertainties and Long-Term Productivity Gains
- C.H. Robinson price target raised to $131 from $117 at Goldman Sachs
- C.H. Robinson upgraded to Overweight at Stephens after ‘solid’ Q3